SAB Biotherapeutics SABS
NASDAQ SABS
$3.20 -0.02 (-0.47%)
As of: Sep 30, 2026 · 1:58 PM EDT

SAB Biotherapeutics, Inc. (SABS) Capital Expenditures (2021 - 2026)

Updated

SAB Biotherapeutics (SABS) reported Capital Expenditures of $1.59 million for Q2 2026, up 61.3% from the prior quarter.

Analysis

SAB Biotherapeutics, Inc. (SABS) Capital Expenditures (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, SAB Biotherapeutics' Capital Expenditures came in at $2.72 million; for FY2025, it was $933,156, up 176.7% from FY2024.

  • Capital Expenditures has a five-year compound annual growth rate of -40.7% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $337,262 in FY2024 (+71.1%), $197,154 in FY2023 (-90.9%), $2.17 million in FY2022 (-80.2%) and $10.94 million in FY2021 (-14.0%).
  • The Q2 2026 figure ranks as the highest quarterly Capital Expenditures since Q4 2021.
  • The high point for year-over-year Capital Expenditures in five years was Q1 2024 (growth of 506.0%); the low point was Q1 2023 (a decline of 98.4%).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.59 Mn
Mar 31, 2026 983,257.00
Dec 31, 2024 55,377.00
Sep 30, 2024 100,300.00
Jun 30, 2024 52,511.00
Mar 31, 2024 129,074.00
Dec 31, 2023 67,864.00
Sep 30, 2023 85,306.00
Jun 30, 2023 22,684.00
Mar 31, 2023 21,300.00
Dec 31, 2022 117,754.00
Sep 30, 2022 78,504.00
Jun 30, 2022 612,832.00
Mar 31, 2022 1.36 Mn
Dec 31, 2021 2.36 Mn
Sep 30, 2021 3.23 Mn
Jun 30, 2021 3.46 Mn
Mar 31, 2021 1.89 Mn
API Access

SAB Biotherapeutics, Inc. Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SABS&period=max&api_key=YOUR_API_KEY